The oxindole/imidazole derivative C16 reduces in vivo brain PKR activation

FEBS Letters

Volumn 581, Issue 23, 2007, Pages 4473-4478

  Ingrand, Sabrina ^a   Barrier, Laurence ^a   Lafay Chebassier, Claire ^a,b   Fauconneau, Bernard ^a,b   Page, Guylène ^a   Hugon, Jacques ^c  

^a UNIVERSITÉ DE POITIERS   (France)

^b POITIERS UNIVERSITY HOSPITAL   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

mTOR; Neuroprotection; Newborn rat; Oxindole imidazole; PKR

Indexed keywords

C16 PROTEIN; IMIDAZOLE DERIVATIVE; INITIATION FACTOR 2ALPHA; MAMMALIAN TARGET OF RAPAMYCIN; OXINDOLE; PROTEIN KINASE R; S6 KINASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

ANALYSIS OF VARIANCE; ANIMALS; BRAIN; EIF-2 KINASE; ENZYME ACTIVATION; EUKARYOTIC INITIATION FACTOR-2; IMIDAZOLES; IMMUNOBLOTTING; INDOLES; PHOSPHORYLATION; PROTEIN KINASES; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION;

RATTUS;

EID: 34548434297     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2007.08.022     Document Type: Article

References (26)

1. Williams B.R. PKR; a sentinel kinase for cellular stress. Oncogene 18 (1999) 6112-6120
2. Raught B., Gingras A.C., and Sonenberg N. The target of rapamycin (TOR) proteins. Proc. Natl. Acad. Sci. USA 98 (2001) 7037-7044
3. Dufner A., and Thomas G. Ribosomal S6 kinase signaling and the control of translation. Exp. Cell Res. 253 (1999) 100-109
4. Fingar D.C., and Blenis J. Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression. Oncogene 23 (2004) 3151-3171
5. Harris T.E., and Lawrence J.C. TOR signaling. Sci. STKE 212 (2003) re15
6. Wang X., and Proud C.G. The mTOR pathway in the control of protein synthesis. Physiology 21 (2006) 362-369
7. Suen K.C., Yu M.S., So K.F., Chang R.C., and Hugon J. Upstream signaling pathways leading to the activation of double-stranded RNA-dependent serine/threonine protein kinase in beta-amyloid peptide neurotoxicity. J. Biol. Chem. 278 (2003) 49819-49827
8. Peel A.L., and Bredesen D.E. Activation of the cell stress kinase PKR in Alzheimer's disease and human amyloid precursor protein transgenic mice. Neurobiol. Dis. 14 (2003) 52-62
9. Chang R.C., Wong A.K., Ng H.K., and Hugon J. Phosphorylation of eukaryotic initiation factor-2alpha (eIF2alpha) is associated with neuronal degeneration in Alzheimer's disease. Neuroreport 13 (2002) 2429-2432
10. Bando Y., Onuki R., Katayama T., Manabe T., Kudo T., Taira K., and Tohyama M. Double-strand RNA dependent protein kinase (PKR) is involved in the extrastriatal degeneration in Parkinson's disease and Huntington's disease. Neurochem. Int. 46 (2005) 11-18
11. Page G., Rioux Bilan A., Ingrand S., Lafay-Chebassier C., Pain S., Perault Pochat M.C., Bouras C., Bayer T., and Hugon J. Activated double-stranded RNA-dependent protein kinase and neuronal death in models of Alzheimer's disease. Neuroscience 139 (2006) 1343-1354
12. Hu Y., and Conway T.W. 2-Aminopurine inhibits the double-stranded RNA-dependent protein kinase both in vitro and in vivo. J. Interferon Res. 13 (1993) 323-328
13. Posti K., Leinonen S., Tetri S., Kottari S., Viitala P., Pelkonen O., and Raunio H. Modulation of murine phenobarbital-inducible CYP2A5, CYP2B10 and CYP1A enzymes by inhibitors of protein kinases and phosphatases. Eur. J. Biochem. 264 (1999) 19-26
14. Nekhai S., Bottaro D.P., Woldehawariat G., Spellerberg A., and Petryshyn R. A cell-permeable peptide inhibits activation of PKR and enhances cell proliferation. Peptides 21 (2000) 1449-1456
15. Jammi N.V., Whitby L.R., and Beal P.A. Small molecule inhibitors of the RNA-dependent protein kinase. Biochem. Biophys. Res. Commun. 308 (2003) 50-57
16. Shimazawa M., and Hara H. Inhibitor of double stranded RNA-dependent protein kinase protects against cell damage induced by ER stress. Neurosci. Lett. 409 (2006) 192-195
17. Lafay-Chebassier C., Paccalin M., Page G., Barc-Pain S., Perault-Pochat M.C., Gil R., Pradier L., and Hugon J. mTOR/p70S6k signalling alteration by Abeta exposure as well as in APP-PS1 transgenic models and in patients with Alzheimer's disease. J. Neurochem. 94 (2005) 215-225
18. Lafay-Chebassier C., Perault-Pochat M.C., Page G., Rioux Bilan A., Damjanac M., Pain S., Houeto J.L., Gil R., and Hugon J. The immunosuppressant rapamycin exacerbates neurotoxicity of Abeta peptide. J. Neurosci. Res. 84 (2006) 1323-1334
19. Chang R.C., Suen K.C., Ma C.H., Elyaman W., Ng H.K., and Hugon J. Involvement of double-stranded RNA-dependent protein kinase and phosphorylation of eukaryotic initiation factor-2alpha in neuronal degeneration. J. Neurochem. 83 (2002) 1215-1225
20. Ferrer I., Bernet E., Soriano E., del Rio T., and Fonseca M. Naturally occurring cell death in the cerebral cortex of the rat and removal of dead cells by transitory phagocytes. Neuroscience 39 (1990) 451-458
21. Blaschke A.J., Weiner J.A., and Chun J. Programmed cell death is a universal feature of embryonic and postnatal neuroproliferative regions throughout the central nervous system. J. Comp. Neurol. 396 (1998) 39-50
22. Engelhardt B. Development of the blood brain barrier. Cell Tissue Res. 314 (2003) 119-129
23. Koromilas A.E., Roy S., Barber G.N., Katze M.G., and Sonenberg N. Malignant transformation by a mutant of the IFN-inducible dsRNA-dependent protein kinase. Science 257 (1992) 1685-1689
24. Meurs E.F., Galabru J., Barber G.N., Katze M.G., and Hovanessian A.G. Tumor suppressor function of the interferon-induced double-stranded RNA-activated protein kinase. Proc. Natl. Acad. Sci. USA 90 (1993) 232-236
25. Yang Y.L., Reis L.F., Pavlovic J., Aguzzi A., Schafer R., Kumar A., Williams B.R., Aguet M., and Weissmann C. Deficient signaling in mice devoid of double-stranded RNA-dependent protein kinase. EMBO J. 14 (1995) 6095-6106
26. Abraham N., Stojdl D.F., Duncan P.I., Methot N., Ishii T., Dube M., Vanderhyden B.C., Atkins H.L., Gray D.A., McBurney M.W., Koromilas A.E., Brown E.G., Sonenberg N., and Bell J.C. Characterization of transgenic mice with targeted disruption of the catalytic domain of the double-stranded RNA-dependent protein kinase, PKR. J. Biol. Chem. 274 (1999) 5953-5962